BG Medicine Inc
BG Medicine, Inc., a diagnostics company, engages in the development and commercialization of novel cardiovascular diagnostic tests to address unmet medical needs in the United States, Europe, and internationally. It offers BGM Galectin-3 test, a novel diagnostic test that measures galectin-3 in blood plasma or serum; and CardioSCORE test that is designed to identify cardiovascular events, such a… Read more
BG Medicine Inc - Asset Resilience Ratio
BG Medicine Inc (BGMD) has an Asset Resilience Ratio of 1.95% as of September 2013. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2004–2012)
This chart shows how BG Medicine Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down BG Medicine Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $265.00K | 1.95% |
| Total Liquid Assets | $265.00K | 1.95% |
Asset Resilience Insights
- Limited Liquidity: BG Medicine Inc maintains only 1.95% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
BG Medicine Inc Industry Peers by Asset Resilience Ratio
Compare BG Medicine Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931 |
Medical Instruments & Supplies | 0.06% |
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 5.12% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 35.75% |
|
Allmed Medical Products Co Ltd Class A
SHE:002950 |
Medical Instruments & Supplies | 3.78% |
|
Inix Technologies Holdings Bhd
KLSE:0094 |
Medical Instruments & Supplies | 0.06% |
|
Focus Point Holdings Bhd
KLSE:0157 |
Medical Instruments & Supplies | 2.30% |
|
Careplus Group Bhd
KLSE:0163 |
Medical Instruments & Supplies | 4.91% |
|
LKL International Bhd
KLSE:0182 |
Medical Instruments & Supplies | 0.38% |
Annual Asset Resilience Ratio for BG Medicine Inc (2004–2012)
The table below shows the annual Asset Resilience Ratio data for BG Medicine Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2012-12-31 | 2.56% | $390.00K | $15.24 Million | +0.39pp |
| 2011-12-31 | 2.16% | $565.00K | $26.11 Million | -14.07pp |
| 2009-12-31 | 16.24% | $2.05 Million | $12.62 Million | -12.94pp |
| 2008-12-31 | 29.18% | $10.28 Million | $35.22 Million | +21.72pp |
| 2004-12-31 | 7.46% | $498.00K | $6.68 Million | -- |